BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18945573)

  • 1. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy.
    Chen H; Lin X; Jin Y; Li W; Ma G; Hu X
    J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
    Kishi K; Morita N; Terada T; Sato M
    Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
    Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
    J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
    Liu Y; Liu D; Wang Y; Zhang W; Zhao F
    J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
    Songsaeng D; Churojana A; Khumthong R; Mahiwan L
    J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced management of congenital vascular malformations: a multidisciplinary approach.
    Lee BB; Bergan JJ
    Cardiovasc Surg; 2002 Dec; 10(6):523-33. PubMed ID: 12453680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body.
    Wohlgemuth WA; Müller-Wille R; Meyer L; Wildgruber M; Guntau M; Heydt SV; Pech M; Zanasi A; Flöther L; Brill R
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):731-739. PubMed ID: 33045393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China.
    Hou R; Guo J; Hu K; Yang Y; Wang L; Kong L; Liu G; Lei D
    J Vasc Surg; 2010 Apr; 51(4):940-5. PubMed ID: 20347690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.
    Lee BB; Do YS; Byun HS; Choo IW; Kim DI; Huh SH
    J Vasc Surg; 2003 Mar; 37(3):533-8. PubMed ID: 12618688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin Foam Treatment of Venous Malformations: A Promising Agent for Effective Treatment with Minimal Swelling.
    Ul Haq F; Mitchell SE; Tekes A; Weiss CR
    J Vasc Interv Radiol; 2015 Oct; 26(10):1484-93. PubMed ID: 26164845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.